Resveratrol in the Prevention and Treatment of Coronary Artery Disease

Inhibitory Effects of Resveratrol on Platelet Activation Induced by Thromboxane A2 Receptor Agonist in Human Platelets

(2011) Yumin Yang et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Resveratrol in cardiovascular health and disease

(2011) Goran Petrovski et al.   Annals of the New York Academy of Sciences

Clinical trials of resveratrol

(2011) Ketan R. Patel et al.   Annals of the New York Academy of Sciences

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice

(2011) Soyoung Kim et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia

(2011) Michael P. Robich et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy

(2010) L. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation

(2010) David O Kennedy et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Resveratrol and Small Artery Compliance and Remodeling in the Spontaneously Hypertensive Rat

(2010) J. Behbahani et al.   AMERICAN JOURNAL OF HYPERTENSION

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

(2010) V. A. Brown et al.   CANCER RESEARCH

Resveratrol Improves Myocardial Perfusion in a Swine Model of Hypercholesterolemia and Chronic Myocardial Ischemia

(2010) M. P. Robich et al.   CIRCULATION

Heart Disease and Stroke Statistics—2011 Update

(2010) Véronique L. Roger et al.   CIRCULATION

SIRT1 Takes a Backseat to AMPK in the Regulation of Insulin Sensitivity by Resveratrol

(2010) M. D. Fullerton et al.   DIABETES

Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol

(2010) Partha Mukhopadhyay et al.   PLoS One

Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration

(2009) Balachandar Venkatesan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

A new insight into resveratrol as an atheroprotective compound: Inhibition of lipid peroxidation and enhancement of cholesterol efflux

(2009) Hicham Berrougui et al.   ATHEROSCLEROSIS

Mechanisms of resveratrol-induced platelet apoptosis

(2009) K. H. Lin et al.   CARDIOVASCULAR RESEARCH

Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes

(2009) G. V. Gnoni et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1

(2009) Dae-Weon Park et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

(2009) K.K.R. Rocha et al.   FOOD AND CHEMICAL TOXICOLOGY

The Cardiovascular Implications of Alcohol and Red Wine

(2008) Adonis Saremi et al.   AMERICAN JOURNAL OF THERAPEUTICS

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

(2008) Il Jin Cho et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice

(2008) Gyeong-Min Do et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY